Philippe Mabo is an expert in Cardiology at Centre Hospitalier Universitaire de Rennes (France). As of July 2026, ScienceLeadR ranks Philippe Mabo in the top 1% of experts worldwide for Cardiac Conduction System Disease and Arrhythmias, Cardiac. Philippe Mabo has authored 509 publications, the most recent in 2026, and is an investigator in 20 clinical trials. SLR score: 1,230 (community average: 125). How the SLR is computed.

LeadR Profile

1 230 ScienceLeadR Reputation 1230
Network Map

Cardiology

Subspecialties: Public Health - Pharmacy - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Rennes

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.
PMID 41973801 — hospitalization, heart failure, heart, atrial fibrillation, risk factors
Eur J Heart Fail20260
Electrical Storm in Patients With Hypertrophic Cardiomyopathy.
PMID 40838922 — cardiovascular diseases, hospital mortality, cardiomyopathy, hypertrophic, radiofrequency ablation, catheter ablation, cardiomyopathies
JACC Clin Electrophysiol20251
Cardiac neuromodulation for ventricular arrhythmias: Current state and future perspectives. A comprehensive review.
PMID 40368054 — tachycardia, ventricular, cardiovascular diseases
Trends Cardiovasc Med20250
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA.
PMID 40752875 — embolism, hemorrhage, stroke, arrhythmias, cardiac, aspirin, atrial fibrillation, apixaban
Heart Rhythm20250
Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial.
PMID 40645433 — diabetes mellitus, embolism, stroke, heart failure, heart, arrhythmias, cardiac, aspirin, atrial fibrillation
Heart Rhythm20253

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Chair: 2 Study Director: 1

By phase:

N/A 13
Phase 4 4
Phase 3 2
Phase 2 1

By status:

Completed 12
Unknown 5
Recruiting 2
Terminated 1

By type:

Interventional 16
Observational 4

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 2
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map